Aim: We aimed to correlate the macroscopic and magnetic resonance imaging (MRI) findings of hepatocellular carcinomas (HCC). Methods: This was a multicenter study, whose study protocol was approved by each Institutional Review Board. One hundred and forty-six resected nodules in 124 patients who were received preoperative hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI (EOB-MRI) were analyzed. In both findings, we compared the 87; 84.8, 62.7 and 81.4; 58.1, 91.3 and 84.2; 70.6, 91.5 and 89, in 
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Introduction
Hepatocellular carcinoma (HCC) is one of the most common neoplasms in Japan, and its incidence has been increasing in the United States and Europe as well. 1 Pathologically, HCCs exhibit morphologic polymorphism and are classified into five types based on their macroscopic findings. 2 Because these types show an intense correlation with the prognosis of HCC including tumor recurrence and/or survival rate, [3] [4] [5] [6] [7] it is important to determine the macroscopic type of HCCs by imaging.
Post-vascular phase of sonazoid-enhanced ultrasonography has been reported as one of the useful methods to predict macroscopic findings. 8 On the other hand, magnetic resonance imaging (MRI) is one of the methods to assess liver tumors objectively.
Gadolinium ethoxybenzyldiethylenetriamine pentaacetic acid (Gd-EOB-DTPA) is one of the hepatocyte-specific agents available for MRI. It is selectively taken up by functioning hepatocytes and shortens T1-relaxasation times of the liver. 9 It provides high detectability of liver tumors, such as HCC and metastatic liver tumors because it is usually not taken up by tumor cells. [10] [11] [12] In this manner, contrast-enhanced MRI using
Gd-EOB-DTPA (EOB-MRI) can clearly demonstrate the border between the tumor and the surrounding liver parenchyma, and has the potential to accurately predict the macroscopic types of HCCs.
In the present study, we correlated the macroscopic MR findings of HCCs to clarify this issue.
Methods
The study protocol of this multicenter study was approved by each institutional review board. Written informed consent was obtained from all participating patients before the MRI examinations and surgical operation.
Patients
Between 2008 and 2009, a total of 233 patients, whose liver nodules were wholly resected and histologically diagnosed with HCC, from 11 Japanese institutions were enrolled in this study. Patients selection was based on the following inclusion criteria: 
Definition of macroscopic findings
We divided the macroscopic findings into five types based on the general rules of the clinical and pathological study of primary liver cancer in Japan Pathological assessment was performed by one or two pathologists in each institution.
MR imaging analysis
On the hepatobiliary phase of EOB-MRI, maximum diameters of the tumors were measured by four radiologists randomly, and were considered as the tumor size (D MRI ).
The MR findings of the tumors at the hepatobiliary phase were classified into five types along with the macroscopic types. Diagnostic criteria of each type are as follows:
(i) SN-IM type tumors are round with an obscure margin (Fig. 1a) ; (ii) SN-DM type tumors are round with a clear margin (Fig. 1b) In this study, we did not assess pre-contrast and early phase of dynamic contrast-enhanced MR images because of obscurity and inhomogeneity of the nodules.
Statistical analysis
Statistical analyses were performed with a statistical software package (Prism, 
Results
The mean value and 95% confidence interval (CI) for the correlation coefficient between D surg and D MRI were 0.961 (95% CI = 0.946-0.972) (Fig. 2) . The median diameter (range) of D surg and D MRI were 25 (1-125) and 24.5 (2-130) mm, respectively.
The differences between both means of diameter were significant (P = 0.0216). Table 1 shows the correlation between the macroscopic and MR findings of HCCs. (Fig. 3) .
Discussion
Independent prognostic factors for recurrence and survival after HCC resection include tumor size, vascular invasion, intrahepatic metastasis, fibrosis and cirrhosis. 7, [13] [14] [15] [16] [17] [18] Macroscopic type is also one predictor of survival rate or recurrence rate. [3] [4] [5] [6] [7] EOB-MRI is one useful tool to assess these factors because it provides higher sensitivity and higher detectability than computed tomography. [10] [11] [12] [13] However, it has been unclear whether the shape of the tumor is shown accurately on hepatobiliary phase demonstrated on EOB-MRI and identified as a significant predictor of recurrence with in 1 year after hepatectomy. 13 However, seven of 31 SN-EG nodules were misinterpreted as SN-DM in this study, namely, they were underestimated. This result would be due to thick slice thickness or assessment of the tumor diameter only at the center of the tumor. We believed that this problem could be resolved by assessment of all images with a thin slice thickness because the kappa value of 3-D-GRE group was higher than that of 2-D-GRE group. It should be noted that five of 17 CMN nodules were underestimated, too.
Regarding the tumor size, patients who had tumors that measured 20 mm or less had a significantly better prognosis in comparison with those with larger tumors. 15, 21 Therefore, 20 mm or less was adopted as the cut-off value of tumor-node-metastasis.
Approximately 23 % of the tumors of 20 mm or less were early hepatocellular carcinomas in a large cohort study. 21 In our study, the diameters of SN-IM tumors were significantly smaller and specificity was higher than in the other groups. For this reason, EOB-MRI may predict a good prognosis of SN-IM because a smaller tumor size or SN-IM, so-called early HCC, indicates a good prognosis. 4, 15 There were no significant differences between the three other groups, like in a previous report. 22 In our study, one of 51 nodules 20 mm or less was CMN type HCC, which is associated with a poor prognosis. It is important that a small CMN type HCC be diagnosed correctly by EOB-MRI.
The concordance rate of all nodules showed moderate agreement (κ = 0.45). The concordance rate was slightly higher when the diameter of the nodules was more than 20 mm (κ = 0.56), because the diameter of most SN-IM nodules, which were misdiagnosed as SN-DM, were not more than 20 mm.
The limitations of our study include the fact that, first, the MRI systems and scan sequences varied in every institution. This is an unavoidable problem associated with all multicenter studies. Second, the pathological assessment was performed by the pathologists of each institution. We believed that their pathological assessment was reliable because all pathological diagnoses were based on the same diagnostic criteria provided by the Liver Cancer Study Group of Japan.
In conclusion, Gd-EOB-DTPA-enhanced MRI could predict the macroscopic pathological findings except for SN-IM. Small tumor size might be helpful to diagnose SN-IM. With advances in technology, we will be able to make a more precise diagnosis on thin slice and high-resolution images by carefully reviewing all images.
